Market Overview

Morning Market Movers

Share:
Related IPCI
Intellipharmaceutics Is 'Not Just A Generic Drug Story,' Brean Capital Says
Morning Market Gainers
Related SPEX
Morning Market Losers
Spherix Announces First Trial of Nortel Patents Since Bankruptcy Scheduled vs Verizon for Q1 2015

IntelliPharmaCeutics International (NASDAQ: IPCI) rose 76.72% to $3.34 following Monday announcement of commercial launch of 15, 30mg Generic Focalin XR.

Spherix (NASDAQ: SPEX) jumped 70.07% to $12.50 after the company announced the settlement agreement and continued monetization of patent portfolio.

Evoke Pharma (NASDAQ: EVOK) shares jumped 41.10% to $11.50 after Aegis Capital initiated coverage on the stock with a Buy rating and a $60.00 price target.

Horizon Pharma (NASDAQ: HZNP) moved up 32.88% to $5.9399 after the company announced an agreement to acquire U.S. rights to VIMOVO. The company also announced pricing of $150 million of 5.00% convertible senior notes.

Posted-In: market moversNews Intraday Update Markets Movers

 

Related Articles (HZNP + EVOK)

Around the Web, We're Loving...